Cite
Neratinib, A Novel HER2-Targeted Tyrosine Kinase Inhibitor
MLA
Jame Abraham, et al. “Neratinib, A Novel HER2-Targeted Tyrosine Kinase Inhibitor.” Clinical Breast Cancer, vol. 16, Oct. 2016, pp. 344–48. EBSCOhost, https://doi.org/10.1016/j.clbc.2016.05.016.
APA
Jame Abraham, Shruti Rakesh Tiwari, & Prasun J. Mishra. (2016). Neratinib, A Novel HER2-Targeted Tyrosine Kinase Inhibitor. Clinical Breast Cancer, 16, 344–348. https://doi.org/10.1016/j.clbc.2016.05.016
Chicago
Jame Abraham, Shruti Rakesh Tiwari, and Prasun J. Mishra. 2016. “Neratinib, A Novel HER2-Targeted Tyrosine Kinase Inhibitor.” Clinical Breast Cancer 16 (October): 344–48. doi:10.1016/j.clbc.2016.05.016.